The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
Goodwin Biotechnology, Inc. Plantation, FL www.GoodwinBio.com (954) 327-9639 DRUG TYPE: Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – packaging SERVICES OFFERED: Aseptic fill/finish, controlled substances, cytotoxic & high-potency compounds, generics, injectables, lyophilized products, parenterals (large volume), parenterals (small volume), peptides, proteins, sterile, and vaccines. "We at GBI are honored to be recognized in three categories of the CMO Leadership Awards, and consider it a testament to the quality of our people and their dedication to our customers. Innovation: Our scientists consistently identify solutions to the most complex challenges. Regulatory: We focus on quality and compliance from cell line engineering through cGMP manufacturing of late-stage clinical trial material. Reliability: Our unique approach helps ensure that we meet and exceed client expectations on every project." — Bansi K. Bhan, interim CEO DRUG TYPE: Pharmaceuticals Haupt Pharma AG Wolfratshausen, Germany and Chesterfield, MO www.haupt-pharma.com 1 314 5 75 00 51 DRUG LIFE CYCLE STAGES: Manufacturing locations: France, Germany, Italy, and Japan Contact: Kevin Koziatek, VP of north american business development Kevin.Koziatek@haupt-pharma.com Research & Development – clincal (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, liquids, lyophilized products, non- sterile, ophthalmics, OTC, parenterals (large volume), parenterals (small volume), peptides, powders (non-sterile), powders (sterile), proteins, semisolids, soft gels, solid dose, solutions & suspensions, sterile, sustained release, topicals, and vaccines. "Haupt Pharma is one of the largest European companies for pharmaceuti- cal contract development and manufacturing. In manufacturing highly potent products, both product safety and employee safety are particularly important to us. This is ensured with our dedicated production area. Under the closed and high-containment principle, processing of highly efficient active ingredients is performed in a closed system. This significantly reduces the risk of contamination of the machine environment and ensures protection of the product, employees and the environment." — Dr. Karl Heinz Brücher, COO of Haupt Pharma AG. SERVICES OFFERED: Aseptic fill/finish, controlled substances, injectables, liquids, lyophilized products, ophthalmics, parenterals (small volume), peptides, proteins, solutions & suspensions, sterile, and vaccines. "We are pleased that JHP was recognized as a leading contract manufacturer. Our Rochester, Michigan site has a 26-year history in contract manufacturing. We've achieved success through a quality-driven, experienced staff and a customer-centric approach. JHP's established infrastructure and deep experience allow us to focus on innovative approaches to meet complex manufacturing needs. Additionally, JHP's extensive experience working with products through their life cycle provides customers with the confidence to focus on their day-to-day business priorities." — Stuart Hinchen, CEO SERVICES OFFERED: Capsules, controlled substances, creams & ointments, gels, high-potency compounds, liquids, non-sterile, powders (non-sterile), semisolids, solid dose, solutions & suspensions, sustained release, and topicals. "We are delighted to have received this award from Life Science Leader for the second year in a row. It acknowledges the tremendous emphasis Halo Pharma puts on product quality and regulatory compliance, indeed the emphasis on quality in everything we do." — Clive Bennett, president and CEO Manufacturing location: Plantation, FL Contact: Dave Cunningham DCunningham@GoodwinBio.com DRUG LIFE CYCLE STAGES: Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, and packaging DRUG TYPE: Pharmaceuticals Halo Pharmaceutical Whippany, NJ www.halopharma.com (973) 428-4000 Manufacturing locations: Whippany, NJ, and Mirabel, Québec, Canada Contact: Sally Langa slanga@halopharma.com JHP Pharmaceuticals Parsippany, NJ www.jhppharma.com (877) 906-7556 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clincal (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form production Manufacturing location: Rochester, MI Contact: Daniel Leone jhpcontractservices@jhppharma.com The CMO Leadership Awards 2012 41 DRUG LIFE CYCLE STAGES